| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.3 | 4e-17 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.31 | 7e-17 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.28 | 2e-16 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.27 | 6e-14 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.26 | 2e-13 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.26 | 9e-13 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.21 | 3e-11 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-11 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.19 | 4e-11 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.18 | 4e-10 |